OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 91 filers reported holding OVID THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,714 | -6.3% | 4,613 | -20.0% | 0.00% | – |
| Q2 2023 | $18,903 | -10.0% | 5,763 | +10.8% | 0.00% | – |
| Q1 2021 | $21,000 | -65.6% | 5,199 | -80.4% | 0.00% | – |
| Q4 2020 | $61,000 | +103.3% | 26,521 | +410.1% | 0.00% | – |
| Q3 2020 | $30,000 | -42.3% | 5,199 | -26.4% | 0.00% | – |
| Q2 2020 | $52,000 | +1200.0% | 7,062 | +229.2% | 0.00% | – |
| Q2 2019 | $4,000 | 0.0% | 2,145 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | -20.0% | 2,145 | 0.0% | 0.00% | – |
| Q4 2018 | $5,000 | -58.3% | 2,145 | 0.0% | 0.00% | – |
| Q3 2018 | $12,000 | -29.4% | 2,145 | 0.0% | 0.00% | – |
| Q2 2018 | $17,000 | +13.3% | 2,145 | 0.0% | 0.00% | – |
| Q1 2018 | $15,000 | +36.4% | 2,145 | +95.4% | 0.00% | – |
| Q4 2017 | $11,000 | +10.0% | 1,098 | 0.0% | 0.00% | – |
| Q3 2017 | $10,000 | -9.1% | 1,098 | 0.0% | 0.00% | – |
| Q2 2017 | $11,000 | – | 1,098 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,319,679 | $5,068 | 20.50% |
| Madison Avenue Partners, LP | 3,648,509 | $14,010,275 | 1.99% |
| CHI Advisors LLC | 864,822 | $3,320,916 | 1.32% |
| EcoR1 Capital, LLC | 6,117,400 | $23,490,816 | 0.79% |
| Rubric Capital Management LP | 5,445,910 | $20,912,294 | 0.78% |
| BVF INC/IL | 6,851,051 | $26,308,036 | 0.71% |
| Artal Group S.A. | 2,500,000 | $9,600 | 0.41% |
| DCF Advisers, LLC | 30,430 | $116,851 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 458,700 | $1,761,408 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,701,228 | $6,531 | 0.03% |